metacardia mr 30tab

Metacardia MR is a pharmaceutical product containing Trimetazidine dihydrochloride, a metabolic agent used primarily in the management of stable angina pectoris. It works by protecting myocardial cells from the effects of ischemia by maintaining cellular energy metabolism. The MR (Modified Release) formulation ensures a steady release of the active ingredient, allowing for twice-daily dosing. It is indicated as an add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line anti-anginal therapies.